Antibacterial Action of Curcumin Against : A Brief Review

Overview

Journal J Trop Med

Publisher Wiley

Specialty Tropical Medicine

Date 2016 Dec 14

PMID 27956904

Citations 68

Authors

Sin-Yeang Teow

Kitson Liew

Syed A Ali

Alan Soo-Beng Khoo

Suat-Cheng Peh

Affiliations

Soon will be listed here.

Abstract

Curcumin, the major constituent of L. (Zingiberaceae family) or turmeric, commonly used for cooking in Asian cuisine, is known to possess a broad range of pharmacological properties at relatively nontoxic doses. Curcumin is found to be effective against (). As demonstrated by experiment, curcumin exerts even more potent effects when used in combination with various other antibacterial agents. Hence, curcumin which is a natural product derived from plant is believed to have profound medicinal benefits and could be potentially developed into a naturally derived antibiotic in the future. However, there are several noteworthy challenges in the development of curcumin as a medicine. infections, particularly those caused by the multidrug-resistant strains, have emerged as a global health issue and urgent action is needed. This review focuses on the antibacterial activities of curcumin against both methicillin-sensitive (MSSA) and methicillin-resistant (MRSA). We also attempt to highlight the potential challenges in the effort of developing curcumin into a therapeutic antibacterial agent.

Citing Articles

Evaluation of hydrogel loading with curcumin and silver nanoparticles: biocompatibilities and anti-biofilm activities.

Hong W, Lee W, Musa S, Kamaruzaman N, Loo C Biometals. 2025; .

PMID: 39979667 DOI: 10.1007/s10534-025-00670-0.

Bioactive Silk Revolution: Harnessing Curcuminoid Dye and Chitosan for Superior Antimicrobial Defence and UV Shielding.

Do K, Ahsan T, Wahab A, Tayyab M, Yin X, Pan N Pharmaceutics. 2025; 16(12.

PMID: 39771490 PMC: 11728638. DOI: 10.3390/pharmaceutics16121510.

The Dynamic Role of Curcumin in Mitigating Human Illnesses: Recent Advances in Therapeutic Applications.

Alam M, Jamir Anwar M, Maity M, Azam F, Jaremko M, Emwas A Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770516 PMC: 11679877. DOI: 10.3390/ph17121674.

Exploring the Interaction of Lipid Bilayers with Curcumin-Laponite Nanoparticles: Implications for Drug Delivery and Therapeutic Applications.

Pawar N, Pena-Figueroa M, Verde-Sesto E, Maestro A, Alvarez-Fernandez A Small. 2024; 20(52):e2406885.

PMID: 39466993 PMC: 11673403. DOI: 10.1002/smll.202406885.

Effect of curcumin on physico-mechanical properties of heat polymerized denture base resin.

Mahajan A, Chander N, Balasubramanian M BMC Oral Health. 2024; 24(1):1300.

PMID: 39462349 PMC: 11514879. DOI: 10.1186/s12903-024-05086-9.

References

Thapliyal R, Maru G . Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo. Food Chem Toxicol. 2001; 39(6):541-7. DOI: 10.1016/s0278-6915(00)00165-4. View

Zhao W, Hu Z, Okubo S, Hara Y, Shimamura T . Mechanism of synergy between epigallocatechin gallate and beta-lactams against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2001; 45(6):1737-42. PMC: 90539. DOI: 10.1128/AAC.45.6.1737-1742.2001. View

Akiyama H, Fujii K, Yamasaki O, Oono T, Iwatsuki K . Antibacterial action of several tannins against Staphylococcus aureus. J Antimicrob Chemother. 2001; 48(4):487-91. DOI: 10.1093/jac/48.4.487. View

. NTP Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CAS No. 8024-37-1) (Major Component 79%-85% Curcumin, CAS No. 458-37-7) in F344/N Rats and B6C3F1 Mice (Feed Studies). Natl Toxicol Program Tech Rep Ser. 1993; 427:1-275. View

Chainani-Wu N . Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med. 2003; 9(1):161-8. DOI: 10.1089/107555303321223035. View

Sharma R, Euden S, Platton S, Cooke D, Shafayat A, Hewitt H . Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res. 2004; 10(20):6847-54. DOI: 10.1158/1078-0432.CCR-04-0744. View

Kang J, Chen J, Shi Y, Jia J, Zhang Y . Curcumin-induced histone hypoacetylation: the role of reactive oxygen species. Biochem Pharmacol. 2005; 69(8):1205-13. DOI: 10.1016/j.bcp.2005.01.014. View

Atsumi T, Fujisawa S, Tonosaki K . Relationship between intracellular ROS production and membrane mobility in curcumin- and tetrahydrocurcumin-treated human gingival fibroblasts and human submandibular gland carcinoma cells. Oral Dis. 2005; 11(4):236-42. DOI: 10.1111/j.1601-0825.2005.01067.x. View

Mohammadi K, Thompson K, Patrick B, Storr T, Martins C, Polishchuk E . Synthesis and characterization of dual function vanadyl, gallium and indium curcumin complexes for medicinal applications. J Inorg Biochem. 2005; 99(11):2217-25. DOI: 10.1016/j.jinorgbio.2005.08.001. View

10.

Maheshwari R, Singh A, Gaddipati J, Srimal R . Multiple biological activities of curcumin: a short review. Life Sci. 2006; 78(18):2081-7. DOI: 10.1016/j.lfs.2005.12.007. View

11.

Cao J, Jia L, Zhou H, Liu Y, Zhong L . Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells. Toxicol Sci. 2006; 91(2):476-83. DOI: 10.1093/toxsci/kfj153. View

12.

Urbina-Cano P, Bobadilla-Morales L, Ramirez-Herrera M, Corona-Rivera J, Mendoza-Magana M, Troyo-Sanroman R . DNA damage in mouse lymphocytes exposed to curcumin and copper. J Appl Genet. 2006; 47(4):377-82. DOI: 10.1007/BF03194648. View

13.

McNally S, Harrison E, Ross J, Garden O, Wigmore S . Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition. Int J Mol Med. 2006; 19(1):165-72. View

14.

Wahl H, Tan L, Griffith K, Choi M, Liu J . Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells. Gynecol Oncol. 2006; 105(1):104-12. DOI: 10.1016/j.ygyno.2006.10.050. View

15.

Appiah-Opong R, Commandeur J, van Vugt-Lussenburg B, Vermeulen N . Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products. Toxicology. 2007; 235(1-2):83-91. DOI: 10.1016/j.tox.2007.03.007. View

16.

Kurien B, Singh A, Matsumoto H, Scofield R . Improving the solubility and pharmacological efficacy of curcumin by heat treatment. Assay Drug Dev Technol. 2007; 5(4):567-76. DOI: 10.1089/adt.2007.064. View

17.

Goel A, Kunnumakkara A, Aggarwal B . Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol. 2007; 75(4):787-809. DOI: 10.1016/j.bcp.2007.08.016. View

18.

Rai D, Singh J, Roy N, Panda D . Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity. Biochem J. 2007; 410(1):147-55. DOI: 10.1042/BJ20070891. View

19.

Anand P, Kunnumakkara A, Newman R, Aggarwal B . Bioavailability of curcumin: problems and promises. Mol Pharm. 2007; 4(6):807-18. DOI: 10.1021/mp700113r. View

20.

Verschoyle R, Steward W, Gescher A . Putative cancer chemopreventive agents of dietary origin-how safe are they?. Nutr Cancer. 2007; 59(2):152-62. DOI: 10.1080/01635580701458186. View